|
|
XPD (Lys751Gln) Genotypes |
Allele Frequency (%) |
|||
| Lys/Lys |
Lys/Gln |
Gln/Gln |
Lys |
Gln |
|
| Control Group (n = 100) |
41 (41.0) |
45 (45.0) |
14 (14.0) |
63.5 |
36.5 |
| Patient Group (n = 90) |
33 (36.7) |
47 (52.2) |
10 (11.1) |
62.8 |
37.2 |
|
|
χ2 = 1.05, p = 0.59 |
χ2 = 0.02, p = 0.88 |
|||
|
|
Merged Genotypes |
||||
| Lys/Lys |
Lys/Gln + Gln/Gln |
||||
| Control Group (n = 100) |
41 (41.0) |
59 (42.0) |
|||
| Patient Group (n = 90) |
33 (36.7) |
57 (60.0) |
|||
|
|
χ2 = 0.37, p = 0.54 |
OR (95% CI) = 1.02 (0.73 - 1.42) |
|||